// App-Quantinova.ai

309 : The utility of serum CA9 in prognostication in prostate cancer.

Researchers

Presenter

  • Alan D. Smith

Principal Investigators

  • Mathew Truong

  • Rob Bristow

  • Bradley Wouters

  • Michael F. Milosevic

  • Anthony M. Joshua

Medical Centers

  • Princess Margaret Hospital, Toronto, ON, Canada

  • University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Carbonic anhydrase IX

Drug/Treatment

  • Docetaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved